About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,780 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,780 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 4,780 trials

CompletedBupropion in Helping Adults Stop SmokingRATIONALE: Bupropion may help people stop smoking by decreasing the symptoms of nicotine withdrawal.NCT00534001·Buffalo, New York CompletedLapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerRATIONALE: Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00962312·Cork and 8 others Active not recruitingA Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic CancerGemcitabine and nab-paclitaxel are one standard of care for metastatic pancreatic adenocarcinoma (mPDAC) but the progression free survival (PFS) of the regimen is only 5.5 months.NCT05026905·Kaohsiung City and 3 others

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

RecruitingINTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)This is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk.NCT07403630·Palermo, Palermo and 1 other

Not yet recruitingMicroenvironment and Immunity of Digestive Cancers - East Paris Multicentric CohortColorectal and pancreatobiliary cancers are the most common digestive cancers.NCT04707365

UnknownClinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System NeoplasmsThis is a open-label, single center to determine the efficacy and safety of IM96 CAR-T cells in Patients With Advanced Digestive System NeoplasmsNCT05287165·Beijing, Beijing Municipality

RecruitingLanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaThis phase III trial compares the effect of using lanreotide before surgery to surgery alone in preventing pancreatic fistulas in patients with pancreatic cancer or a pancreatic…NCT06807437·Birmingham, Alabama and 117 others

Not yet recruitingStructured Case-Finding for Pancreatic Ductal Adenocarcinoma in Swiss Primary Care: A Feasibility StudyPancreatic ductal adenocarcinoma (PDAC) is diagnosed at an advanced, incurable stage in more than 80% of cases in Switzerland.NCT07723781·Zurich, Canton of Zurich

RecruitingEUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)This is a single arm study in the treatment of pancreatic ductal adenocarcinoma (PDAC).NCT05723107·New York, New York

CompletedAdjuvant Effect of Chloroquine on GemcitabineThe purpose of this study is to evaluate the safety by defining the maximum tolerated dose (MTD) of Choloroquine when combined with Gemcitabine, and to evaluate preliminary…NCT01777477·Zurich, Canton of Zurich

UnknownPRIORITY-CONNECT 2 Pilot TrialThe provision of preoperative interventions (prehabilitation: including exercise, nutrition, and psychological treatment) have been reported to reduce postoperative complications…NCT06212700·Sydney, New South Wales and 1 other

Active not recruitingPalbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial evaluates the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers.NCT05554367·Birmingham, Alabama and 264 others

CompletedUltrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal AdenocarcinomaPatients with inoperable pancreatic cancer have extremely poor prognosis with five year survival below 8% in Norway.NCT04146441·Trondheim

CompletedKEBI-Cyto Study - Use of the Biocartis IdyllaUse of the Biocartis Idylla ™ platform for the detection of Epidermal Growth Factor Receptor, B-RAF and K-RAS proto-oncogene mutations in liquid based cytology specimens and blood…NCT04236102·Truro, Cornwall

RecruitingA Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D MutationThis is a phase 2 study.NCT07784374·Shanghai, Shanghai Municipality

Not yet recruitingSpanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde CholangiopancreatographyEndoscopic retrograde cholangiopancreatography (ERCP) is a technique which combines endoscopic and radiological vision and allows for therapeutic procedures on pathologies of the…NCT06670547

UnknownInterventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersOur institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ), Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a…NCT01438385·New York, New York

RecruitingPara-aortic Lymph Node Metastasis in Resectable Pancreatic CancerLymph node metastases are a strong prognostic predictor for pancreatic cancer.NCT06065891·Odense and 5 others

Active not recruitingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsStudy of NGM831 as Monotherapy and in Combination with Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsNCT05215574·Gilbert, Arizona and 8 others

RecruitingA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid…NCT07488676·Birmingham, Alabama and 20 others

PreviousPage 6 of 239Next